The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

Story by Lao-Tzu Allan-Blitz, MD, MPH, and Jeffrey D. Klausner, MD, MPH Drug commercials have become commonplace in the U.S. The average American watches more than nine drug advertisements a day, or ...

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based ...

Gilead stock toppled Thursday after CVS HealthCVS said it won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now. The decision is based on clinical, financial and ...

SALT LAKE CITY — University of Utah biochemist Wesley Sundquist achieved yet another milestone last week when the Food and Drug Administration approved an antiviral drug for HIV prevention based on ...

In 1962, spurred by the discovery that thalidomide, marketed in Europe as a sleeping pill, caused severe birth defects, Congress granted FDA the authority to regulate drug advertisements. The FDA ...